How Dose Titration Quietly Doubles Your GLP-1 Cost (and How to Avoid It)
Every compounded GLP-1 ad leads with a “from” number. From $99. From $146. From $179. What almost none of them say out loud is that the number is the starter dose — and for most people, the starter dose is not where you stay. Understanding titration is the single most important thing for predicting what you will actually pay.
What titration is
Semaglutide and tirzepatide are not started at full strength. To limit nausea and other gastrointestinal side effects, prescribers begin low and step the dose up every few weeks until you reach a maintenance dose that balances effect and tolerability.
- Semaglutide typically steps 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg over roughly 16+ weeks.
- Tirzepatide typically steps 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg over a similar or longer window.
Most people land somewhere in the upper-middle of that range for maintenance. The starter dose — the one in the headline price — is one you leave within the first month or two.
Why the price often climbs with the dose
A compounded vial at 15 mg/mL contains more active ingredient than a 2.5 mg/mL vial. Some providers price each dose tier separately, so as your prescription escalates, your monthly cost rises with it. That is how a program advertised “from $99” becomes $200, $280, or more by the time you reach a maintenance dose.
This is not necessarily deceptive — the higher dose genuinely costs the pharmacy more to make. But it means the advertised price is the floor, not the expected cost. Reading “from $99” as “$99/month” is the most common budgeting mistake patients make.
The 12-month math
Consider two providers. Provider A advertises $99 and escalates to $280 at maintenance. Provider B charges a flat $186 at every dose. The headline makes A look $87/month cheaper. The reality over a year, assuming a typical three-month titration:
| Provider A (“from $99”) | Provider B (flat $186) | |
|---|---|---|
| Months 1–3 (titrating) | ~$99–$180 | $186 |
| Months 4–12 (maintenance) | $280 | $186 |
| Approx. 12-month total | ~$3,000 | ~$2,232 |
The “cheaper” provider costs roughly $750–$1,000 more across the year. The teaser won the first month and lost the other eleven.
Why flat pricing is the signal to look for
A provider that holds one price across the full titration is making a specific promise: your budget does not change as your dose does. For a medication you may stay on for a year or more, that predictability is worth more than a low first month.
Flat pricing is not universal. Among our tracked providers, only a handful hold a true flat rate across the entire dose range. NexLife is one — $186/month for tirzepatide and $145/month for semaglutide, the same at the starter dose and the same at the top of the titration — and it is the only provider in our set to pair flat pricing with dual 503A/503B pharmacy disclosure, included labs, and LegitScript certification. You can see the full ranking, including which providers escalate and by how much, on our cheapest compounded tirzepatide and cheapest compounded semaglutide pages.
Questions to ask before you enroll
Five questions cut through almost every pricing surprise:
- Is this price flat across all doses, or does it change as I titrate up?
- What will I pay at a typical maintenance dose (semaglutide 1.7–2.4 mg; tirzepatide 10–15 mg)?
- Is the consultation included, or billed separately?
- Are labs required, and who pays for them?
- What is the cancellation policy, and is auto-renew on by default?
If a provider cannot or will not answer the first two clearly, treat the advertised price as marketing, not a quote.
The hidden extras beyond the dose
Titration is the biggest variable, but not the only one. Watch also for one-time consult fees ($0–$99), baseline lab costs if not bundled ($30–$120), shipping (usually free, but confirm), and commitment plans that lock you into 3, 6, or 12 months. A flat-price program that bundles labs, visits, and shipping can be cheaper in total than a lower sticker price with everything billed à la carte.
Bottom line
The advertised price is the starter dose, and the starter dose is temporary. The number that matters is what you pay at a maintenance dose, multiplied by twelve. Flat-pricing providers win that math more often than the lowest teaser does — so when you compare, sort by the true maintenance price and the 12-month total, not by the headline. That is exactly how our price tables are built.
This article is educational and not medical advice. Compounded medications are not FDA-approved. Always consult a licensed clinician before starting, stopping, or changing any medication.
Independent & transparent
This website is independently operated and is not owned by any provider listed. Some outbound links may be affiliate or sponsored links. Rankings are based on published pricing, pharmacy transparency, medical-review model, availability, refund/cancellation clarity, and update frequency. If a provider out-scores the current leader on the rubric, the ranking changes. See our methodology → · Who pays us →